Imax (IMAX) Research & Development (2010 - 2026)

Imax has disclosed Research & Development across 17 years of filings, most recently posting $1.7 million for Q2 2026.

• In Q2 2026, Research & Development rose 7.33% year-over-year to $1.7 million; the TTM figure through Jun 2026 stood at $6.4 million (up 71.3% YoY), while the FY2025 annual figure was $5.8 million, up 13.97% from the prior year.
• Research & Development came in at $1.7 million for Q2 2026 at Imax, down from $1.8 million in the prior quarter.
• In the past five years, Research & Development ranged from a high of $2.8 million in Q3 2023 to a low of -$265000.0 in Q3 2024.
• Average Research & Development over 5 years is $1.7 million, with a median of $1.6 million recorded in 2022.
• Year-over-year, Research & Development tumbled 109.56% in 2024 and soared 667.92% in 2025.
• Over 5 years, Research & Development stood at $1.6 million in 2022, then surged by 66.69% to $2.7 million in 2023, then tumbled by 57.75% to $1.2 million in 2024, then grew by 26.17% to $1.5 million in 2025, then advanced by 14.06% to $1.7 million in 2026.
• Per Business Quant data, the three most recent Research & Development figures were $1.7 million in Q2 2026, $1.8 million in Q1 2026, and $1.5 million in Q4 2025.